Durham, NC, United States · North America
OncologyRare diseaseCell & gene therapyVaccines
FDAEMAPMDANMPA
SCALE 270 studies
Open to sponsorsSterile / advanced-therapy specialistView OncologyCell & gene therapyRare diseaseVaccines
NMPAFDAEMAPMDA
SCALE 270 studies
Open to sponsorsSterile / advanced-therapy specialistView OncologyVaccinesRare disease
NMPAFDAEMAPMDA
SCALE 270 studies
Open to sponsorsSterile / advanced-therapy specialistView OncologyVaccines
PMDAFDAEMANMPA
SCALE 270 studies
Open to sponsorsAdvanced-therapy activeView Princeton, NJ, United States · United States
OncologyInfectious diseaseVaccines
FDAEMAMHRAHealth Canada
SCALE 270 studies
Open to sponsorsAdvanced-therapy activeView PC
Zug, Switzerland · Europe
OncologyRare disease
FDAEMAPMDAMHRA
SCALE 270 studies
Open to sponsorsAdvanced-therapy activeView London, United Kingdom · Europe
OncologyRare disease
FDAEMAPMDAMHRA
SCALE 230 studies
Open to sponsorsSelectiveView Irvine, United States · North America
Not presented as a therapeutic-area list. Company service pages name oncology (PDXCDXorthotopicsyngeneic
SCALE 00 studies
Open to sponsorsGeneral clinicalView Company site lists OncologyDermatologyRespiratoryBiosimilars and Vaccines as therapeutic areas
SCALE 120 studies
Open to sponsorsGeneral clinicalView